Fulcrum Therapeutics
FULC
#7803
Rank
A$0.34 B
Marketcap
$5.58
Share price
0.00%
Change (1 day)
2.27%
Change (1 year)

EPS for Fulcrum Therapeutics (FULC)

EPS in 2023 (TTM): -$2.70

According to Fulcrum Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.76. In 2022 the company made an earnings per share (EPS) of -$3.80 a decrease over its 2021 EPS that were of -$3.51.

EPS history for Fulcrum Therapeutics from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.70-28.87%
2022-$3.808.3%
2021-$3.51-18.51%
2020-$4.30-31.36%
2019-$6.2777.16%
2018-$3.54

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.34 21.11%๐Ÿ‡บ๐Ÿ‡ธ USA